CLINICAL ROLE -
Patients With CLL Present Heterogeneously
Certain patients may present asymptomatically, affecting treatment options.
Monitoring Treatment, Managing Quality of Life in Patients With ccRCC
The pharmacist’s role may vary across different practices and institutions.
Treatment of cGVHD Requires a Patient-Centered Approach
The complexity of the disease and number of treatment options can necessitate a personalized approach.
Pharmacists May See Patients With NSCLC More Often Than Other Care Team Members
This frequency can allow for faster observation of toxicities and adherence issues.
Guiding Principles in the Management of cGVHD
In addition to the current principles and treatment regimens, there are upcoming data on myelofibrosis drugs that could be reported as early as 2024.
Pharmacists Can Help Address Treatment Challenges for Patients With Cholangiocarcinoma
Treatment options can be limited for this patient population.
Medication Adherence to BTK Inhibitors Can Pose Challenges for Patients With CLL
Although treatment is effective, AEs remain difficult for patients.
Additional Guidelines Around Biomarkers Could Improve Adjuvant Treatment of Early-Stage NSCLC
The fast pace of information can make it difficult to efficiently apply data to care.
With High Medication Burden of GVHD, Pharmacists Play a Critical Role in Supporting Education, Medication Adherence
Pharmacists can improve both quality of life and financial toxicity for patients.
Advocacy, Education of Individuals With Myeloproliferative Neoplasms Are Important to Support Patient Engagement, Outcomes
Pharmacists also have the resources to help advocate for better care for patients.
Pharmacists’ Involvement in Treatment Decisions for NSCLC Has Increased and Evolved
A plethora of targeted therapies, biomarker-driven therapies, and immunotherapies are now available.
Data Show Melanoma Site to Be Independent High-Risk Factor for Recurrence, Poor Outcomes
High-risk areas for disease progression include genitalia and the scalp.
NSCLC May Be an Increasingly Biomarker-Driven Disease
An expert shares information on risk factors and controversies around testing.
Pharmacists Can Provide Education on Management, Prevention Strategies for Chronic Graft-vs-Host Disease
Pharmacologic approaches can reduce the risk of chronic GVHD.